Exclusion criteria (67) Patient cohort PowerPoint PPT Presentation
1
Exclusion criteria (67) Patient cohort <100 (50) Re-analysis of same cohort (5) Off topic (12) Studies on genetic polymorphisms in Hodgkin N=112 Unique studies selected for review N=45 *7 studies shared between non-HLA susceptibility and prognosis **1 study shared between prognosis and secondary malignancies/toxicities HLA susceptibil ity N=11 Non-HLA susceptibil ity N=19 GWAS N=5 Prognosis N=15* Secondary malignancies/ toxicities N=3** Supplementary figure 1.
description
Studies on genetic polymorphisms in Hodgkin N=112. Exclusion criteria (67) Patient cohort
Transcript of Exclusion criteria (67) Patient cohort PowerPoint PPT Presentation
Exclusion criteria (67)Patient cohort <100 (50)Re-analysis of same cohort (5)Off topic (12)
Studies on genetic polymorphisms in Hodgkin
N=112
Unique studies selected for review
N=45
*7 studies shared between non-HLA susceptibility and prognosis**1 study shared between prognosis and secondary malignancies/toxicities
HLAsusceptibility
N=11
Non-HLA susceptibility
N=19
GWASN=5
PrognosisN=15*
Secondary malignancies/ toxicities
N=3**
Supplementary figure 1.